Mocht u kanker-actueel de moeite waard vinden en ons willen ondersteunen om kanker-actueel online te houden dan kunt u ons machtigen voor een periodieke donatie via donaties: https://kanker-actueel.nl/NL/donaties.html of doneer al of niet anoniem op - rekeningnummer NL79 RABO 0372931138 t.n.v. Stichting Gezondheid Actueel in Amersfoort. Onze IBANcode is NL79 RABO 0372 9311 38
Elk bedrag is welkom. En we zijn een ANBI instelling dus uw donatie of gift is in principe aftrekbaar voor de belasting.

En als donateur kunt u ook korting krijgen bij verschillende bedrijven:

https://kanker-actueel.nl/NL/voordelen-van-ops-lidmaatschap-op-een-rijtje-gezet-inclusief-hoe-het-kookboek-en-de-recepten-op-basis-van-uitgangspunten-van-houtsmullerdieet-te-downloaden-enof-in-te-zien.html

28 maart 2016: de studie bij kinderen met de Mellinn 850 in het UMCG Groningen staat hier geregistreerd:

http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=5659

21 februari 2016: Bron: Pubmed en Mellinn website

Low Level laser voorkomt en geneest mucositis - aantasting van de slijmvliezen - in mond en keel zo tonen veel studies aan. Zie o.a. deze search in pubmed. Een trouwe bezoeker en donateur van onze website (waarvoor dank) wees me op een Nederlands ontwikkeld laser apparaatje dat iedereen thuis kan gebruiken om mucositis te voorkomen of te behandelen als er al mucositis is ontstaan. En dit apparaatje, hoewel nog altijd ca. € 500,-- kostend, is betaalbaar en gemakkelijk in het gebruik. Voor alle duidelijkheid wij hebben geen enkel belang bij dit bedrijf, Mellinn.

low level laser van Melinn

Foto: Melinn650 low level laser voor thuisgebruik

Nu is Low Level laser dus al jarenlang een veel gebruikte manier om o.a bij kinderen die een stamceltransplantatie ondergaan de effecten van de hoge dosis chemo op met name de slijmvliezen in de mond tegen te gaan. In kinderziekenhuizen, ook bv. in het Sophia Kinderziekenhuis Rotterdam wordt low level laser al jaren gebruikt. Maar bij volwassenen wordt deze methode veel minder vaak ingezet terwijl het toch een manier is die pijnloos en zonder gevaar, zonder bijwerkingen is. Maar de meeste oncologen wijzen kankerpatienten hier niet op.

Maar niet alleen bij een stamceltransplantie (bij 60% tot 80% van de patiënten ) worden de slijmvliezen aangetast maar ook bij bestraling van mond en keel en ook bij chemokuren wordt bij 20% tot 40% van de patienten de slijmvliezen in mond en keel aangetast. Zo ook bij chemo en bestraling van patiënten met mond- en keelkanker 80% tot 100%. (Ik kan er zelf over meepraten). Daarom dit artikel om u hier op te wijzen.

Zoals in de pubmed search te zien is wordt low level laser al vele jaren onderzocht en toegepast, niet alleen bij kanker maar ook bij chronische ontstekingen. Ook in de literatuurlijsten per kankersoort staan enkele studies met low level laser vermeld. Ik heb een recente review studie eruit gehaald waarbij low level laser therapy gebruikt wordt bij patienten met mond- en keelkanker..

Conclusie: Onze meta-analyse toont aan dat prophylactische LLLT - low level laseer therapy het risico op ernstige mucositis en andere vormen van slijmvliesaantasting significant vermindert bij patiënten die behandeld worden voor mond- en keelkanker. Low level laser therapy verminderde ook de pijn, de noodzaak van opiaten (morfine) en onvoorziene onderbreking van de bestraling. De consistentie van zowel de eerste metingen als de tweede metingen bevestigen de betrouwbaarheid van deze resutlaten. Zie verderop het abstract van deze studie.

Zie onderstaande grafiek voor de resultaten uit deze reviewstudie:

Het volledige studierapport: Effect of Prophylactic Low Level Laser Therapy on Oral Mucositis: A Systematic Review and Meta-Analysis is gratis in te zien.

Hier het abstract van de studie:

Prophylactic LLLT reduced severe mucositis and pain in patients with cancer and HSCT recipients. Future research should identify the optimal characteristics of LLLT and determine feasibility in the clinical setting.

PLoS One. 2014; 9(9): e107418.

Published online 2014 Sep 8. doi: 10.1371/journal.pone.0107418

PMCID: PMC4157876

Effect of Prophylactic Low Level Laser Therapy on Oral Mucositis: A Systematic Review and Meta-Analysis

Sapna Oberoi,¹ Gabriele Zamperlini–Netto,¹ Joseph Beyene,^2,³ Nathaniel S. Treister,⁴ and Lillian Sung^1,^2,^*

Michael Hamblin, Editor

Author information ► Article notes ► Copyright and License information ►

This article has been cited by other articles in PMC.

Abstract

Background

Objective was to determine whether prophylactic low level laser therapy (LLLT) reduces the risk of severe mucositis as compared to placebo or no therapy.

Methods

MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials were searched until February 2014 for randomized controlled trials (RCTs) comparing prophylactic LLLT with placebo or no therapy in patients with cancer or undergoing hematopoietic stem cell transplantation (HSCT). All analyses used random effects models.

Results

Eighteen RCTs (1144 patients) were included. Prophylactic LLLT reduced the overall risk of severe mucositis (risk ratio (RR) 0.37, 95% confidence interval (CI) 0.20 to 0.67; P = 0.001). LLLT also reduced the following outcomes when compared to placebo/no therapy: severe mucositis at the time of anticipated maximal mucositis (RR 0.34, 95% CI 0.20 to 0.59), overall mean grade of mucositis (standardized mean difference −1.49, 95% CI −2.02 to −0.95), duration of severe mucositis (weighted mean difference −5.32, 95% CI −9.45 to −1.19) and incidence of severe pain (RR 0.26, 95% CI 0.18 to 0.37).

Conclusion

Prophylactic LLLT reduced severe mucositis and pain in patients with cancer and HSCT recipients. Future research should identify the optimal characteristics of LLLT and determine feasibility in the clinical setting.

Data Availability

The authors confirm that all data underlying the findings are fully available without restriction. All relevant data are within the paper and its Supporting Information files.

Go to:

References

1. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, et al. (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100: 1995–2025. [PubMed]

2. Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, et al. (2003) Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66: 253–262. [PubMed]

3. Blijlevens N, Schwenkglenks M, Bacon P, D'Addio A, Einsele H, et al. (2008) Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy–European Blood and Marrow Transplantation Mucositis Advisory Group. J Clin Oncol 26: 1519–1525. [PubMed]

4. Woo SB, Sonis ST, Monopoli MM, Sonis AL (1993) A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients. Cancer 72: 1612–1617. [PubMed]

5. Vera-Llonch M, Oster G, Hagiwara M, Sonis S (2006) Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer 106: 329–336. [PubMed]

6. Epstein JB, Beaumont JL, Gwede CK, Murphy B, Garden AS, et al. (2007) Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire. Cancer 109: 1914–1922. [PubMed]

7. McCann S, Schwenkglenks M, Bacon P, Einsele H, D'Addio A, et al. (2009) The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT. Bone Marrow Transplant 43: 141–147. [PubMed]

8. Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, et al. (2003) The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98: 1531–1539. [PubMed]

9. Vera-Llonch M, Oster G, Ford CM, Lu J, Sonis S (2007) Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies. Support Care Cancer 15: 491–496. [PubMed]

10. Peterman A, Cella D, Glandon G, Dobrez D, Yount S (2001) Mucositis in head and neck cancer: economic and quality-of-life outcomes. J Natl Cancer Inst Monogr 45–51. [PubMed]

11. Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, et al. (2014) MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer [PMC free article] [PubMed]

12. Migliorati C, Hewson I, Lalla RV, Antunes HS, Estilo CL, et al. (2013) Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients. Support Care Cancer 21: 333–341. [PubMed]

13. Worthington HV, Clarkson JE, Bryan G, Furness S, Glenny AM, et al. (2011) Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev CD000978. [PubMed]

14. Antunes HS, Herchenhorn D, Small IA, Araujo CMM, Viegas CMP, et al. (2013) Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation. Radiother Oncol 109: 297–302. [PubMed]

15. Arbabi-Kalati F, Arbabi-Kalati F, Moridi T (2013) Evaluation of the effect of low level laser on prevention of chemotherapy-induced mucositis. Acta Medica Iranica 51: 157–162. [PubMed]

16. Gautam AP, Fernandes DJ, Vidyasagar MS, Maiya AG, Vadhiraja BM (2012) Low level laser therapy for concurrent chemoradiotherapy induced oral mucositis in head and neck cancer patients - a triple blinded randomized controlled trial. Radiother Oncol 104: 349–354. [PubMed]

17. Gautam AP, Fernandes DJ, Vidyasagar MS, Maiya GA (2012) Low level helium neon laser therapy for chemoradiotherapy induced oral mucositis in oral cancer patients - a randomized controlled trial. Oral Oncol 48: 893–897. [PubMed]

18. Gouvea de Lima A, Villar RC, de Castro G Jr, Antequera R, Gil E, et al. (2012) Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study. Int J Radiat Oncol Biol Phys 82: 270–275. [PubMed]

19. Hodgson BD, Margolis DM, Salzman DE, Eastwood D, Tarima S, et al. (2012) Amelioration of oral mucositis pain by NASA near-infrared light-emitting diodes in bone marrow transplant patients. Support Care Cancer 20: 1405–1415. [PubMed]

20. Oton-Leite AF, Correa de Castro AC, Morais MO, Pinezi JCD, Leles CR, et al. (2012) Effect of intraoral low-level laser therapy on quality of life of patients with head and neck cancer undergoing radiotherapy. Head Neck 34: 398–404. [PubMed]

21. Silva GBL, Mendonca EF, Bariani C, Antunes HS, Silva MAG (2011) The prevention of induced oral mucositis with low-level laser therapy in bone marrow transplantation patients: a randomized clinical trial. Photomed Laser Surg 29: 27–31. [PubMed]

22. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) The PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. PLoS Med 6 (7) e1000097 doi:10.1371/journal.pmed.1000097 [PMC free article] [PubMed]

23. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33: 159–174. [PubMed]

24. WHO (1979) WHO Handbook for Reporting Results of Cancer Treatment. Publication No. 48. Geneva: WHO.

25. Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31: 1341–1346. [PubMed]

26. Henry DH, Viswanathan HN, Elkin EP, Traina S, Wade S, et al. (2008) Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S. Support Care Cancer. 16: 791–801. [PubMed]

27. Higginson IJ, Armes J, Krishnasamy M (2004) Introduction, in fatigue in cancer. In: Armes J, Krishnasamy M, Higginson IJ, editors. Fatigue in Cancer. Oxford: Oxford University Press. pp. xvii–xxi.

28. Vogelzang NJ, Breitbart W, Cella D, Curt GA, Groopman JE, et al. (1997) Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 34: 4–12. [PubMed]

29. Tardieu C, Cowen D, Thirion X, Franquin JC (1996) Quantitative scale of oral mucositis associated with autologous bone marrow transplantation. Eur J Cancer B Oral Oncol 32B: 381–387. [PubMed]

30. Sonis ST, Eilers JP, Epstein JB, LeVeque FG, Liggett WH Jr, et al. (1999) Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group. Cancer 85: 2103–2113. [PubMed]

31. Collins JJ, Devine TD, Dick GS, Johnson EA, Kilham HA, et al. (2002) The measurement of symptoms in young children with cancer: the validation of the Memorial Symptom Assessment Scale in children aged 7–12. J Pain Symptom Manage 23: 10–16. [PubMed]

32. Collins SL, Moore RA, McQuay HJ (1997) The visual analogue pain intensity scale: what is moderate pain in millimetres? Pain 72: 95–97. [PubMed]

33. Collins JJ, Byrnes ME, Dunkel IJ, Lapin J, Nadel T, et al. (2000) The measurement of symptoms in children with cancer. J Pain Symptom Manage 19: 363–377. [PubMed]

34. Schulz KF, Chalmers I, Hayes RJ, Altman DG (1995) Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273: 408–412. [PubMed]

35. Arun Maiya G, Sagar MS, Fernandes D (2006) Effect of low level helium-neon (He-Ne) laser therapy in the prevention & treatment of radiation induced mucositis in head & neck cancer patients. Indian J Med Res 124: 399–402. [PubMed]

36. Antunes HS, Herchenhorn D, Small I, Araujo C, Cabral E, et al. (2013) Cost-effectiveness of low-level laser therapy (LLLT) in head and neck cancer patients submitted to concurrent chemoradiation. Support Care Cancer 21: S199.

37. Gautam AP, Fernandes DJ, Vidyasagar MS, Maiya AG, Nigudgi S (2013) Effect of low-level laser therapy on patient reported measures of oral mucositis and quality of life in head and neck cancer patients receiving chemoradiotherapy–a randomized controlled trial. Support Care Cancer 21: 1421–1428. [PubMed]

38. Pires-Santos GM, Ferreira MFL, Oliveira SCPS, Monteiro JSC, Brugnera A, et al. (2012) Use of Laser photobiomodulation in the evolution of oral mucositis associated with CMF chemotherapy protocol in patients with breast cancer-Case Report. Medicina Oral, Patologia Oral y Cirugia Bucal 17: S252.

39. Chor A, Torres SR, Maiolino A, Nucci M (2010) Low-power laser to prevent oral mucositis in autologous hematopoietic stem cell transplantation. Eur J Haematol 84: 178–179. [PubMed]

40. Antunes HS, de Azevedo AM, da Silva Bouzas LF, Adao CAE, Pinheiro CT, et al. (2007) Low-power laser in the prevention of induced oral mucositis in bone marrow transplantation patients: a randomized trial. Blood 109: 2250–2255. [PubMed]

41. Cruz LB, Ribeiro AS, Rech A, Rosa LGN, Castro CG Jr, et al. (2007) Influence of low-energy laser in the prevention of oral mucositis in children with cancer receiving chemotherapy. Pediatr Blood Cancer 48: 435–440. [PubMed]

42. Schubert MM, Eduardo FP, Guthrie KA, Franquin J-C, Bensadoun R-JJ, et al. (2007) A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation. Support Care Cancer 15: 1145–1154. [PubMed]

43. Lopes CdO, Mas JRI, Zângaro RA (2006) Prevenção da xerostomia e da mucosite oral induzidas por radioterapia com uso do laser de baixa potência. Radiol bras 39: 131–136.

44. Bensadoun RJ, Franquin JC, Ciais G, Darcourt V, Schubert MM, et al. (1999) Low-energy He/Ne laser in the prevention of radiation-induced mucositis. A multicenter phase III randomized study in patients with head and neck cancer. Support Care Cancer 7: 244–252. [PubMed]

45. Bensadoun RJ, Ciais G (2002) Radiation-and chemotherapy-induced mucositis in oncology: results of multicenter phase III studies. J Oral Laser App 115–120.

46. Cowen D, Tardieu C, Schubert M, Peterson D, Resbeut M, et al. (1997) Low energy Helium-Neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: results of a double blind randomized trial. Int J Radiat Oncol Biol Phys 38: 697–703. [PubMed]

47. Khouri VY, Stracieri ABPL, Rodrigues MC, Moraes DAd, Pieroni F, et al. (2009) Use of therapeutic laser for prevention and treatment of oral mucositis. Braz Dent J 20: 215–220. [PubMed]

48. Oton-Leite AF, Elias LS, Morais MO, Pinezi JC, Leles CR, et al. (2013) Effect of low level laser therapy in the reduction of oral complications in patients with cancer of the head and neck submitted to radiotherapy. Spec Care Dentist 33: 294–300. [PubMed]

49. Bjordal JM, Bensadoun RJ, Tuner J, Frigo L, Gjerde K, et al. (2011) A systematic review with meta-analysis of the effect of low-level laser therapy (LLLT) in cancer therapy-induced oral mucositis. Support Care Cancer 19: 1069–1077. [PubMed]

50. Bowen JM, Elad S, Hutchins RD, Lalla RV (2013) Methodology for the MASCC/ISOO Mucositis Clinical Practice Guidelines Update. Support Care Cancer 21: 303–308. [PubMed]

51. Stolik S, Delgado JA, Perez A, Anasagasti L (2000) Measurement of the penetration depths of red and near infrared light in human “ex vivo” tissues. J Photochem Photobiol B 57: 90–93. [PubMed]

52. Enwemeka CS (2001) Attenuation and penetration of visible 632.8 nm and invisible infra-red 904 nm light in soft tissues. Laser Ther 95–101.

53. Hode L (2005) The importance of coherence. Photomed Laser Surg 23: 431–434. [PubMed]

54. Enwemeka CS (2006) The place of coherence in light induced tissue repair and pain modulation. Photomed Laser Surg 24: 457. [PubMed]

55. Schubert MM, Williams BE, Lloid ME, Donaldson G, Chapko MK (1992) Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Development of an oral mucositis index. Cancer 69: 2469–2477. [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science

low level laser, mucositis, slijmvliesontstekingen, aften, chemo, bestraling, radiotherapie, stamceltransplantatie, Mellinn